FDA Monitoring Market For Devices More Medical Than Beauty
This article was originally published in The Rose Sheet
Executive Summary
Dermabrasion device maker Dermapen is the latest to receive a warning letter for marketing a product that affects body structure or function without going through the required regulatory pathway for medical devices. FDA highlights similar warnings from the past decade on a newly updated webpage.